Statera Biopharma Inc. Soared
Tue, Jun 27, 2023 at 07:53 PM
Statera Biopharma Inc. (STAB:NASDAQ) shot up at $0.03, representing a gain of 25.5%. On Tue, Jun 27, 2023, STAB:NASDAQ hit a New 1-Month Intraday High of $0.04. From Tue, Jun 13, 2023, the stock recorded 22.22% Up Days and 20.00% Green Days
The stock spiked on Wed, Jan 11, 2023 at $0.11 with a volume of 3M+.
About Statera Biopharma Inc. (STAB:NASDAQ)
Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.
Top 10 Gainers:
- Black Diamond Therapeutics, Inc. (BDTX:NASDAQ), 235.87%
- AC Immune SA (ACIU:NASDAQ), 71.72%
- Leafly Holdings Inc. (LFLY:NASDAQ), 54.81%
- Centogene N.V. (CNTG:NASDAQ), 50.82%
- Tivic Health Systems Inc. (TIVC:NASDAQ), 38.96%
- Ryvyl Inc Com (New) (RVYL:NASDAQ), 36.29%
- CalciMedica Inc Com (New) (CALC:NASDAQ), 33.13%
- VivoPower International PLC (VVPR:NASDAQ), 32.35%
- Statera Biopharma Inc. (STAB:NASDAQ), 25.46%
- Enovix Corporation (ENVX:NASDAQ), 25.23%